Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
NTLA
NTLA News & Events
-
Add to Watchlist
Trade NTLA
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
NTLA News
Shopify and Others Tumble as Cathie Wood Buys on Dip
4d ago
Fool
Intellia Therapeutics to Participate in Upcoming Investor Conferences
5d ago
Newsfilter
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
ARK Invest Increases Holdings in Robinhood and Others Amid Stock Declines
Apr 30 2026
Yahoo Finance
Intellia Therapeutics Prices $180M Public Offering
Apr 29 2026
seekingalpha
ARK Investment Management Increases NTLA Holdings
Apr 28 2026
stocktwits
Intellia Reports Positive Phase 3 Results for Lonvo-z in Hereditary Angioedema
Apr 28 2026
NASDAQ.COM
Intellia Therapeutics Launches $150M Public Offering
Apr 27 2026
seekingalpha
Show More News
NTLA Events
No data
NTLA Monitor News
Intellia Initiates BLA Submission for Lonvo-z in HAE Treatment
Apr 30 2026
Intellia Reports Positive Phase 3 Results for Lonvo-z in Hereditary Angioedema
Apr 29 2026
Intellia's NTLA stock surges ahead of Phase 3 trial results
Apr 27 2026
Intellia's FDA Approval Boosts Clinical Trial for Nex-z
Mar 03 2026
Intellia's Shares Surge as FDA Lifts Hold on Nexiguran Trial
Mar 02 2026
FDA Lifts Clinical Hold on Intellia's Phase 3 Trial
Jan 28 2026
Intellia Therapeutics shares surge amid market gains
Jan 27 2026
ARK Invest Acquires Shares of Intellia, Boosting Stock Price
Jan 22 2026
NTLA Earnings Analysis
No Data
People Also Watch
